Early Triple Negative Breast Cancer: Conventional Treatment and Emerging Therapeutic Landscapes

Triple negative breast cancers (TNBCs) are characterized by worse prognosis, higher propensity to earlier metastases, and shorter survival after recurrence compared with other breast cancer subtypes. Anthracycline- and taxane-based chemotherapy is still the mainstay of treatment in early stages, alt...

Descripción completa

Detalles Bibliográficos
Autores principales: Diana, Anna, Carlino, Francesca, Franzese, Elisena, Oikonomidou, Olga, Criscitiello, Carmen, De Vita, Ferdinando, Ciardiello, Fortunato, Orditura, Michele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7225917/
https://www.ncbi.nlm.nih.gov/pubmed/32235297
http://dx.doi.org/10.3390/cancers12040819

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7225917/
https://www.ncbi.nlm.nih.gov/pubmed/32235297
http://dx.doi.org/10.3390/cancers12040819

Ejemplares similares